Tuesday, 29 September 2026 · London Edition · 07:30 London

AI's risk is leaving Nvidia's balance sheet. That's the tell.

Signals

⚡ Convergence radar: Buy NVDA×4Buy SMH×4Buy TSM×4

Nvidia buyback

Nvidia added $150bn to its buyback, the largest authorization in history, lifting total capacity to $235bn through January 2028. WSJ, FT, MarketWatch and The Information all run the same announcement; only MarketWatch flags the unusually long horizon. The context is the point — NVDA is up 21% YTD after two years of triple-digit gains and sits 3% below its 52-week high on 14.6x forward earnings, so this is a cash-return story, not a demand signal. Watch whether free cash flow funds it, or whether the buyback quietly crowds out capex.

NVDA

Buy Nvidia⚡ — Four outlets confirm the record $235bn authorization, but with NVDA on 14.6x forward earnings and 3% below its 52-week high, the buyback becomes the marginal buyer if AI orders slow.

$228.9 +1.68%
SMH

Buy Semiconductors⚡ — Nvidia's confidence lifts sentiment across the chip complex it anchors, though SMH is 11% below its 52-week high and down 1.2% on the week.

$600.0 -1.08%
TSM

Buy TSMC⚡ — A $235bn return-of-capital program implies Nvidia still expects heavy foundry volume; TSM at 20.7x forward sits 6% below its 52-week high.

$452.9 +0.50%

AI risk transfer

Nvidia is approaching insurers to take on AI build-out risk, with two FT pieces — Companies and Markets desks — running the story the same morning. The aim is to pull more Wall Street capital into financing the boom, letting Nvidia book AI orders without carrying all the residual. That's a clever piece of engineering and a signal: when the shovel-seller starts offloading shovel risk, the marginal risk buyer is an insurance balance sheet that has never priced an AI demand cycle. No counterparties, no premiums, no deal size disclosed. The first disclosed premium is the number to watch.

CB

Buy Chubb — Specialty insurers earn premium on newly written AI build-out risk, and CB at 1.7x book and 9% below its 52-week high means a new risk pool isn't in the price.

$331.4 -0.60%
AIG

Buy AIG — AIG trades at 0.94x book and 2% above its 52-week low, so new AI premium is optionality — but the unfamiliarity of the risk cuts both ways.

$72.78 -1.87%
BX

Buy Blackstone — Private credit is the intended destination for this risk, yet BX has fallen 7.6% in the past week and sits 35% below its 52-week high.

$114.6 -3.26%

AI capex returns

FT Alphaville puts a required-return test on hyperscaler AI capex — what breakeven rate does the spending have to earn? CNBC, separately, reports AI firms are borrowing take-or-pay contracts from the energy sector, with firm start dates and payment regardless of usage. Read together, the financing structure moves risk off hyperscaler balance sheets and onto power and infrastructure counterparties. MSFT sits 8% below its 52-week high on 21.5x forward earnings, so the returns question is now the weakest link in the bull case. Watch the first disclosed contract value.

VST

Buy Vistra — Take-or-pay converts AI demand into contracted revenue for generators, and VST at 13.3x forward sits 36% below its 52-week high.

$138.0 -0.32%
LNG

Buy Cheniere — Cheniere is the original take-or-pay franchise the AI crowd is copying, and it is up 36% YTD while sitting 10% below its 52-week high.

$269.6 +0.41%
MSFT

Watch Microsoft — Single-source and headline-only, but the breakeven question is the right one, and MSFT at 21.5x forward with record capex means the return test bites directly.

$509.2 -1.35%

Duration pain

UBS published a two-sided view that higher-for-longer rates split bonds into winners and losers, with no extractable detail on the specific picks. The tape already agrees with the loser half: TLT is at its 52-week low, down 3.8% on the week and 9.7% YTD, and HYG, LQD and TIP all sit at 0% above their own 52-week lows. TBT, the 2x short-duration Treasury ETF, is 1% from a 52-week high after a 7.6% week. Treat the relative-value framing as the takeaway, not the tickers.

TBT

Buy Short-duration Treasuries — TBT is up 7.6% in a week and 1% from a 52-week high — the crowded side of a single-source call, so low conviction on chasing it.

$41.53 +1.52%
TLT

Sell Long-duration Treasuries — UBS is single-source, but TLT pinned at 0% above its 52-week low with a 3.8% weekly decline is the trend confirming itself.

$78.62 -0.88%
HYG

Sell High yield credit — Higher refinancing costs hit the most levered borrowers first, and HYG is at its 52-week low, down 1.4% on the week.

$77.54 -0.41%
LQD

Watch Investment grade credit — UBS lists investment grade among the winners, but LQD at 0% above its 52-week low says the market hasn't agreed yet.

$102.5 -0.72%

Tokenized collateral

Franklin Templeton's tokenized money-market shares are now accepted as collateral on Bybit, backing USDT and USDC trading credit lines while still earning yield on the underlying. CoinDesk's Ian Allison has the detail, and the mechanic is what matters — a tokenized MMF that yields while posted as margin is a better asset than idle stablecoin, and it puts a TradFi product inside crypto's plumbing. BEN is up 37% YTD on 10.2x forward earnings, so the franchise is already re-rating. No facility size or fee split was disclosed.

BEN

Buy Franklin Templeton — CoinDesk alone has it, but the venue is named and the product is live; BEN is up 37% YTD on 10.2x forward earnings as the listed pure beneficiary.

$32.68 -1.03%
BLK

Watch BlackRock — BlackRock runs the competing tokenized money-market fund, so this is now a head-to-head race with no disclosed size on either side.

$1071 -1.39%
COIN

Watch Coinbase — Coinbase owns the onshore version of this plumbing but sits 52% below its 52-week high after a 4.6% weekly decline.

$191.8 -1.70%

AI deposit risk

MarketWatch's Steve Goldstein reports Apollo's chief economist arguing agentic AI — Muse and peers — could coordinate a bank run. The note is short, with no mechanism, timeframe or named institution, which is exactly how a tail risk looks before it's priced. Nothing in bank valuations reflects faster deposit velocity: KRE sits 10% below its 52-week high and XLF is roughly flat YTD. This is cheap insurance, not a core view.

KRE

Sell Regional banks — Single-source and abstract, with KRE 10% below its 52-week high, so this is cheap insurance rather than a core position.

$70.55 -1.40%
XLF

Sell US financials — A systemic deposit-velocity risk is a broad drag on bank valuations, and XLF is roughly flat YTD with 8% of downside to its 52-week high already recovered.

$54.19 -1.19%
APO

Watch Apollo — Apollo is the messenger here, not the target, and it is down 4.1% on the week and 22% below its 52-week high on its own merits.

$119.0 -2.21%

Starship milestone

Starship reached orbit for the first time and deployed the latest Starlink satellites, per WSJ Business and The Information. It's the milestone the reusable-launch thesis needed: a working Starship resets the cost curve for every competing launch provider. Rocket Lab is 52% below its 52-week high and AST SpaceMobile 54% below its own, so neither chart has panicked yet. T-Mobile is Starlink's US direct-to-cell partner, so more satellites in orbit is coverage upside for it.

TMUS

Buy T-Mobile US — T-Mobile is Starlink's US direct-to-cell partner, so more satellites in orbit improves its coverage story, though the stock is 3% above its 52-week low.

$166.4 +0.62%
RKLB

Sell Rocket Lab — A fully reusable Starship is the toughest possible competitor for every other launch provider, and RKLB at 52% below its 52-week high hasn't repriced that yet.

$72.19 -2.38%
ASTS

Sell AST SpaceMobile — Faster Starlink deployment widens SpaceX's lead in direct-to-phone connectivity, and ASTS is already 54% below its 52-week high, down 4.2% on the week.

$61.00 -1.31%

Japan autos

Nidec will book an impairment above ¥600bn ($3.8bn), almost entirely on EV traction-motor systems, with shares down 17% and CEO Kishida resigning over the e-axle unit — Nikkei had the number before any filing. The company has already exited a China EV drive-parts JV and Cambodian production, so this is a retreat from a business it spent a decade building. Nissan separately targets 80% US local production by 2030 from 65% and has stopped making a plug-in hybrid for North America. One is an EV unwind; the other is tariff-driven reshoring.

LEA

Buy Lear — Nissan's 65%-to-80% localization target means more US-assembled content, and Lear at 7.1x forward is the domestic supplier expression.

$120.2 -2.01%
6594.T

Sell Nidec — Nikkei broke the ¥600bn impairment before any company filing, and a 17% single-day fall plus a CEO exit at the e-axle unit suggests the write-down isn't fully marked.

6902.T

Sell Denso — Nidec's EV motor write-down invites the same question about other Japanese parts makers carrying heavy EV-investment books.

US-China thaw

The US and China each published lists for mutual tariff cuts on $30bn of non-sensitive goods — Christmas ornaments, lumber, camels. China's Ministry of Commerce says the cuts happen simultaneously but gave no date, and soybeans and LNG are absent from China's list. So it's symbolically real and economically small, days after Trump hosted Xi in Washington. FXI is down 14% YTD and 19% below its 52-week high, which means the market is positioned for relief rather than priced for it.

FXI

Buy China large caps — The cut list is real but tiny relative to the trade relationship, and FXI at 19% below its 52-week high and down 14% YTD means de-escalation is not yet in the price.

$34.17 +0.62%
EEM

Buy Emerging markets — A US-China truce reduces the single largest risk hanging over EM, though EEM has already run 19.5% YTD and sits 6% below its 52-week high.

$67.20 -1.15%

India food rules

India's regulator issued notices to Nestlé, PepsiCo, Coca-Cola, Danone, KFC and McDonald's over prominent front-of-pack warnings on high sugar, salt and fat. The illustrative fact: Fanta sold in India reportedly carries more sugar than the same product in Germany, the UK or the US. India is one of the fastest-growing packaged-food markets, so reformulation and labelling costs hit growth rather than current earnings. PEP at 1% above its 52-week low and YUM at 3% above theirs mean the news lands on already-broken charts.

KO

Sell Coca-Cola — Coca-Cola is named in the notices, and KO at 24.7x forward and 6% below its 52-week high is the least discounted of the three, so it has the most room to re-rate lower.

$87.18 -0.72%
PEP

Sell PepsiCo — PepsiCo is also named, so reformulation and labelling costs hit India growth plans, and PEP trades 1% above its 52-week low after a 9.7% YTD decline.

$128.5 -0.10%
YUM

Sell Yum! Brands — KFC's parent was named in the notices, adding menu and marketing costs in a key growth market while the stock sits 3% above its 52-week low.

$138.3 -0.25%

Cruise upgrades

BofA upgraded Royal Caribbean to buy with a $330 target — roughly 36% above Friday's close — after seven straight down weeks and a 26% drawdown from the Aug 5 peak. Analyst Andrew Didora models at least 4% net yield growth in Q4 2026, the best in the industry, with cruise spend reaccelerating to mid-teens growth in July and August. Deutsche Bank upgraded the same day. The offset is fuel: USO is up 4.1% on the week. RCL at 11.9x forward is priced for a recession the bookings aren't showing.

RCL

Buy Royal Caribbean — BofA and Deutsche Bank upgraded the same day on a $330 target 36% above Friday's close, with RCL 26% off its Aug 5 peak after seven down weeks at 11.9x forward.

“BofA upgraded Royal Caribbean to buy, keeping a $330 target, arguing travel and cruise demand are strong enough to offset oil and macro worries.”

$242.6 -0.05%
CCL

Buy Carnival — The mid-teens cruise-spend growth cited by the analyst lifts the whole sector, and CCL at 8.6x forward is 35% below its 52-week high.

$22.14 -0.49%
NCLH

Buy Norwegian Cruise Line — The same demand read-through applies to the third major operator, though NCLH is the weakest chart at 43% below its 52-week high and 37% down YTD.

$14.31 -2.05%

Most original take

FT Alphaville · 28 Sept 2026

What is the AI capex breakeven rate?

FT Alphaville asks the question the AI bull case hasn't answered: what return does hyperscaler capex have to earn to break even? Reframing the spend as a required-return problem rather than a demand story changes which evidence matters — depreciation schedules, utilisation, pricing power — none of which the buyback-and-insurers headlines address. If the required return sits above what data centres can earn, today's $150bn Nvidia buyback and the insurer risk-transfer both read as financial engineering around a capex cycle being extended, not validated.

Read original ↗

Our view

Strip today's headlines back and they are one story told four ways: the AI capex cycle is being refinanced, not expanded. Nvidia authorizes $235bn of buybacks; Nvidia shops AI build-out risk to insurers; AI firms sign energy-style take-or-pay contracts; FT Alphaville asks what return the capex has to earn. Meanwhile the funding side of that same trade is cracking. TLT is at its 52-week low, down 3.8% on the week and 9.7% YTD, and it has company — HYG, LQD and TIP all sit at 0% above their own 52-week lows. You don't refinance a decade of capex into a bond market that is repricing higher for longer.

The de-rating is already visible in everything that needs long-dated capital. Constellation Energy is 37% below its 52-week high, Vistra 36%, Blackstone 35%, Apollo 22%. Those are the counterparties the AI build-out now depends on — insurers, private credit, power producers — and the market has spent 2026 marking them down. That is the tension the buyback headlines paper over.

The case against our read is strong and simple. Nvidia is 3% below its all-time high on 14.6x forward earnings and just put $235bn of buyback capacity behind the stock; companies that expect their customers' returns to disappoint don't do that. Honda sits 3% below its 52-week high, Marriott added 3.0% last week, and EWJ is 2% off its high — Japan and travel are working. If the 10-year stabilises and the Fed's next meeting delivers a cut, TLT's 52-week low is the entry of the year and every financialisation story reads as capital markets deepening. Watch the front end: a curve pricing fewer than three cuts kills our thesis.

What's missing from today's coverage is the funding side. Not one of the fifteen clusters asks who finances a $235bn buyback, or what yield an insurer would demand to hold AI residual risk. Four fixed-income ETFs sitting at 52-week lows got one UBS note between them. The cleanest expression isn't a single ticker — it's dispersion: long the toll-takers with contractual cash flow, like Cheniere's take-or-pay franchise or T-Mobile's Starlink partnership, against the balance sheets absorbing the residual. That trade doesn't need a view on AI demand. It needs someone to price the risk.

Yesterday's signals, today

From the London Edition on 28 Sept 2026 — 4/5 signals moved in the predicted direction.

Share this edition